Anti-Beta-2 Microglobulin Antibody Clone B2M/1118

Observed Antibody Staining Data By Tissue Type:

Variations in Beta-2 Microglobulin antibody staining intensity in immunohistochemistry on tissue sections are present across different anatomical locations. An intense signal was observed in cells in the white pulp in spleen, germinal center cells in the lymph node and tonsil, hematopoietic cells in the bone marrow, macrophages in lung, non-germinal center cells in the lymph node and tonsil, pneumocytes in lung, respiratory epithelial cells in the bronchus and nasopharynx and squamous epithelial cells in the tonsil. More moderate antibody staining intensity was present in cells in the white pulp in spleen, germinal center cells in the lymph node and tonsil, hematopoietic cells in the bone marrow, macrophages in lung, non-germinal center cells in the lymph node and tonsil, pneumocytes in lung, respiratory epithelial cells in the bronchus and nasopharynx and squamous epithelial cells in the tonsil. Low, but measureable presence of Beta-2 Microglobulin could be seen inadipocytes in breast and mesenchymal tissue, bile duct cells in the liver, cells in the granular layer in cerebellum, cells in the molecular layer in cerebellum, cells in the seminiferous ducts in testis, chondrocytes in mesenchymal tissue, exocrine glandular cells in the pancreas, fibroblasts in skin and mesenchymal tissue, glandular cells in the breast and parathyroid gland, glial cells in the caudate nucleus, cerebral cortex and hippocampus, hepatocytes in liver, myocytes in heart muscle and skeletal muscle, myoepithelial cells in the breast, neuronal cells in the caudate nucleus, cerebral cortex and hippocampus, ovarian stroma cells in the ovary, peripheral nerve in mesenchymal tissue, peripheral nerve/ganglion in colon, Purkinje cells in the cerebellum, smooth muscle cells in the smooth muscle, squamous epithelial cells in the cervix and uterine and vagina. We were unable to detect Beta-2 Microglobulin in other tissues. Disease states, inflammation, and other physiological changes can have a substantial impact on antibody staining patterns. These measurements were all taken in tissues deemed normal or from patients without known disease.